Table 1.
Treatment | 1st assessment (before DI) | 2nd assessment (2.5 h after DI) | 3rd assessment (4.5 h after DI) |
---|---|---|---|
Placebo | 1.54 (0.46) | 1.43 (0.30) | 1.44 (0.39) |
Haloperidol | 1.54 (0.44) | 1.41 (0.39) | 1.53 (0.42) |
Values represent mean ratings across-subject means (SD). DI, drug intake.